Pentoxifylline modifies three-dimensional collagen lattice model contraction and expression of collagen types I and III by human fibroblasts derived from post-burn hypertrophic scars and from normal skin


Autoria(s): ISAAC, Cesar; MATHOR, Monica Beatriz; BARIANI, Giovani; PAGGIARO, Andre Oliveira; HERSON, Marisa Roma; GOLDENSTEIN-SCHAINBERG, Claudia; CARRASCO, Solange; TEODORO, Walcy Rosolia; YOSHINARI, Natalino Hajime; FERREIRA, Marcus Castro
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Fibroblasts are thought to be partially responsible for the persisting contractile forces that result in burn contractures. Using a monolayer cell culture and fibroblast populated collagen lattice (FPCL) three-dimensional model we subjected hypertrophic scar and non-cicatricial fibroblasts to the antifibrogenic agent pentoxifylline (PTF - 1 mg/mL) in order to reduce proliferation, collagen types I and III synthesis and model contraction. Fibroblasts were isolated from post-burn hypertrophic scars (HSHF) and non-scarred skin (NHF). Cells were grown in monolayers or incorporated into FPCL`s and exposed to PTF. In monolayer, cell number proliferation was reduced (46.35% in HSHF group and 37.73% in NHF group, p < 0.0001). PTF selectively inhibited collagen III synthesis in the HSHF group while inhibition was more evident to type I collagen synthesis in the NHF group. PTF also reduced contraction in both (HSHF and NHF) FPCL. (C) 2009 Elsevier Ltd and ISBI. All rights reserved.

Identificador

BURNS, v.35, n.5, p.701-706, 2009

0305-4179

http://producao.usp.br/handle/BDPI/21548

10.1016/j.burns.2008.11.017

http://dx.doi.org/10.1016/j.burns.2008.11.017

Idioma(s)

eng

Publicador

ELSEVIER SCI LTD

Relação

Burns

Direitos

restrictedAccess

Copyright ELSEVIER SCI LTD

Palavras-Chave #Cell culture #Fibroblast culture #Pentoxifylline #Collagen #Collagen type I #Collagen type III #Three-dimensional contraction model #Hypertrophic scars #Normal skin #WOUND CONTRACTION #LASER-DOPPLER #PROLIFERATION #GLYCOSAMINOGLYCAN #MYOFIBROBLASTS #FIBRONECTIN #INVITRO #KELOIDS #Critical Care Medicine #Dermatology #Surgery
Tipo

article

original article

publishedVersion